Cleared Traditional

K162484 - Lung Nodule Assessment and Comparison O...

K162484 is the FDA 510(k) clearance for Lung Nodule Assessment and Comparison O... by Philips Medical Systems Nederland B.V.. It is a Class 2 Radiology device (product code LLZ) cleared through the Traditional 510(k) pathway after a 169-day FDA review.

K162484 · Philips Medical Systems Nederland B.V. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 2017
Decision
169d
Days
Class 2
Risk

K162484 is an FDA 510(k) clearance for the Lung Nodule Assessment and Comparison Option (LNA). Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Philips Medical Systems Nederland B.V. (5684 Pc Best, NL). The FDA issued a Cleared decision on February 23, 2017 after a review of 169 days - an extended review cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all Philips Medical Systems Nederland B.V. devices

Submission Details

510(k) Number K162484 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 07, 2016
Decision Date February 23, 2017
Days to Decision 169 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
62d slower than avg
Panel avg: 107d · This submission: 169d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Consultant

Qsite
Yoram Levy

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 1092
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K162484.
Synapse 3D Perfusion Analysis
K162287 · Fujifilm Medical Systems U.S.A, Inc. · Apr 2017
Move Forward 3D Motion Simulation Service
K162559 · Biomet, Inc. · Mar 2017
FDX Console (DR-ID300CL) Software
K170451 · Fujifilm Medical Systems U.S.A, Inc. · Mar 2017
syngo.MR General, syngo.MR Cardiology, syngo.MR Neurology
K163294 · Siemens Medical Solutions USA, Inc. · Feb 2017
NobelClinician, DTX Studio implant
K163122 · Nobel Biocare AB · Jan 2017
Multi Modality Viewer
K163574 · Vital Images, Inc. · Jan 2017